Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
Safonov A, Lee M, Brown DN, Boscolo Bielo L, Mehine M, Bandlamudi C, O'Leary B, Shao H, Vicente L, Muldoon D, Zhu A, Ros S, Marra A, Selenica P, Bieche I, Wubbenhorst B, Ferraro E, Courtois L, El Botty R, Ahmed M, Moiso E, An JA, Donoghue MTA, Will M, Pareja F, Nizialek E, Lukashchuk N, Sofianopoulou E, Liu Y, Huang X, Chappey C, Staniszewska AD, Ross D, Mandelker D, Ladanyi M, Schultz N, Berger MF, Scaltriti M, Reis-Filho JS, Li BT, Offit K, Norton L, Shen R, Maxwell KN, Couch F, Domchek SM, Marangoni E, Shah S, Albertella MR, Serra V, Weigelt B, Solit DB, Nathanson KL, Robson ME, Turner NC, Chandarlapaty S, Razavi P.
Safonov A, et al. Among authors: huang x.
Nature. 2026 Apr;652(8110):752-762. doi: 10.1038/s41586-026-10197-0. Epub 2026 Mar 4.
Nature. 2026.
PMID: 41781623
Free PMC article.